At a glance
ClinicalIndex Comparison RecordN/ACompleted· 273 enrolled
Drug / intervention
Vitamin D3 +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Determination of RDA for Vitamin D in Caucasian and African American Women
In Brief
A clinical study evaluating Vitamin D3 and Calcium Citrate (Citracal) for Osteoporosis and Aging. Completed, enrolled 273 participants across 1 site.
Detailed Summary
The purpose of this study is to examine the effects of several doses of vitamin D on hormones related to bone, calcium absorption, bone density and muscle strength.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoporosis, Aging
CountriesUnited States
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
First PostedMay 2007
Primary CompletionAug 2011
TodayJul 2026
First PostedMay 14, 2007
Enrollment StartApr 1, 2007
Primary CompletionAug 1, 2011
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 19.1 years ago
Interventions
Vitamin D3dietary
Orally for one year
Calcium Citrate (Citracal)dietary
Orally for one year; dosage adjusted so that calcium intake is 1200-1400mg daily